823 results on '"Steurer, Stefan"'
Search Results
2. Molecular control of endurance training adaptation in male mouse skeletal muscle
3. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities
4. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
5. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors
6. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors
7. SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 Tumors
8. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors
9. KLK7 expression in human tumors: a tissue microarray study on 13,447 tumors
10. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
11. More than the clock: distinct regulation of muscle function and metabolism by PER2 and RORα
12. Sarkoidose als Paradebeispiel einer granulomatösen Erkrankung
13. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence
14. Steroidogenic Acute Regulatory Protein Is a Useful Marker for Sex-Cord-Stroma Tumors and Normal and Neoplastic Adrenocortical Tissue
15. Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications
16. Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors
17. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors
18. Synaptophysin and chromogranin A expression analysis in human tumors
19. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
20. Dying of VOC-202012/01 — multimodal investigations in a death case of the SARS-CoV-2 variant
21. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
22. Frequency of Androgen Receptor Positivity in Tumors: A Study Evaluating More Than 18,000 Tumors.
23. Pathologie und genetische Faktoren des kleinzelligen Lungenkarzinoms
24. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers
25. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas
26. Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin
27. Automated Prognosis Marker Assessment in Breast Cancers Using BLEACH&STAIN Multiplexed Immunohistochemistry
28. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors
29. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators
30. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer
31. Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
32. E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
33. p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
34. Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases
35. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
36. Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
37. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer
38. High homogeneity of MMR deficiency in ovarian cancer
39. Rapid Remote Online Evaluation in Endoscopic Diagnostics: An Analysis of Biopsy-Proven Respiratory Cytopathology
40. Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues
41. Concordance between MITS and conventional autopsies for pathological and virological diagnoses
42. Imaging of human airways by endoscope-compatible dynamic microscopic optical coherence tomography
43. Minimally Invasive Tissue Sampling via Post Mortem Ultrasound: A Feasible Tool (Not Only) in Infectious Diseases—A Case Report
44. MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
45. Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
46. Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
47. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy
48. Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
49. Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany
50. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.